Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Effect of overexpression of A3B and RNA editing calling in mouse tissues [WES]

ABSTRACT: To test if A3B has RNA editing activity we performed SNV calling from WES of 8 mouse livers (Samples 1-8) and 8 pancreas (Samples 7-16)

ORGANISM(S): Mus musculus

PROVIDER: GSE209722 | GEO | 2023/07/25

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Similar Datasets

Effect of overexpression of A3B and RNA editing calling in mouse tissues [RNA-seq]

Project description:To test if A3B has RNA editng activity we performed SNV calling from RNA-seq of 6 mouse lungs (Samples 7-12), 8 mouse livers (Samples 14-20) and 8 pancreas (Samples 21-28) We then performed gene expression profiling analysis using data obtained from RNA-seq of 6 mouse livers (Samples 1-6), 6 mouse lungs (Samples 7-12), 8 mouse livers (Samples 14-20) and 8 pancreas (Samples 21-28)

2023-07-25 | GSE209721 | GEO

Effect of depletion of A3B on gene expression of 92.1 cells and overexpression of A3B on gene expression of MEL290 cells

Project description:To investigate the function of A3B, we established 92.1 cell lines with A3B knocked down and MEL290 cell lines with A3B overexpression. We then performed gene expression profiling analysis using data obtained from RNA-seq of 4 different cell lines with two replicates.

2023-06-07 | GSE218751 | GEO

Decoding the Genes that A3B regulated

Project description:Chromatin immunoprecipitation DNA-sequencing (ChIP-seq) for A3B in OMM2.3 and 92.1 cells.

2023-06-07 | GSE218753 | GEO

Decoding the Genomic regions that R-loop distributed associated with A3B expression

Project description:R-loop CUT&Tag in OMM2.3 cells with A3B knocked down

2023-06-07 | GSE218754 | GEO

Effect of overexpression of A3B and RNA editing calling in mouse tissues

Project description:This SuperSeries is composed of the SubSeries listed below.

2023-07-25 | GSE209723 | GEO

Chromosome 11 analysis in myeloid malignancies - WES

Project description:Blood samples from patients with myeloid malignancies were analyzed using whole exome sequencing (WES). Data set from genotyping by microarray of the same samples has been deposited in ArrayExpress under accession number E-MTAB-1845 (https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-1845/).

2013-11-01 | E-MTAB-1850 | biostudies-arrayexpress

hepatoblastoma WES

Project description:WES sequencing of 34 hepatoblastoma tumors and controls

| PRJEB11805 | ENA

WES and TRS of PPHN

Project description:WES of PPHN

| PRJEB25712 | ENA

The LL-100 panel: 100 DSMZ cell lines for blood cancer studies; WES

Project description:For many years, immortalized cell lines have been used as model systems for cancer research. Cell line panels were established for basic research and drug development, but did not cover the full spectrum of leukemia and lymphoma. Therefore, we now developed a novel panel (LL-100), 100 cell lines covering 22 entities of human leukemia and lymphoma including T-cell, B-cell and myeloid malignancies. Importantly, all cell lines are unequivocally authenticated and assigned to the correct tissue. Cell line samples were proven to be free of mycoplasma and virus contamination. Whole exome sequencing (WES) and RNA sequencing (RNA-seq) of the hundred authenticated leukemia-lymphoma cell lines were conducted with a uniform methodology to complement existing data on these publicly available cell lines. This part captures WES. This data set will be useful for understanding the function of oncogenes and tumor suppressor genes and to develop targeted therapies.

2019-05-28 | E-MTAB-7722 | biostudies-arrayexpress

WES-CDS17

Project description:WES analysis of CDS17 and T-CDS17 cell lines

| PRJEB31233 | ENA